Tekla Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Tekla Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-78,197	Closed	-$4.04M	–	177
2022 Q3	$4.04M	Hold	78,197	–	–	0.17%	86
2022 Q2	$1.94M	Hold	78,197	–	–	0.08%	115
2022 Q1	$1.96M	Hold	78,197	–	–	0.07%	126
2021 Q4	$2.85M	Hold	78,197	–	–	0.09%	119
2021 Q3	$1.34M	Hold	78,197	–	–	0.04%	146
2021 Q2	$1.05M	Sell	78,197 -66,250	-46%	-$1.63M	0.03%	168
2021 Q1	$7.4M	Hold	144,447	–	–	0.25%	99
2020 Q4	$8.94M	Hold	144,447	–	–	0.31%	86
2020 Q3	$7.92M	Buy	+144,447	New	+$7.78M	0.3%	79

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tekla Capital Management's CCXI Position: Q4 2022 in Review

Tekla Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 78,197 shares — an estimated $4.04M sold.

Tekla Capital Management first reported a position in CCXI in Q3 2020 and held it in 9 quarters. The position peaked at $8.94M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Tekla Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Tekla Capital Management sold 78,197 ChemoCentryx, Inc. shares in Q4 2022, an estimated $4.04M.
Tekla Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 9 quarters.
Tekla Capital Management's ChemoCentryx, Inc. position peaked at $8.94M in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Tekla Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.